Alnylam Pharmaceuticals
ALNY
#645
Rank
A$48.56 B
Marketcap
$376.54
Share price
-0.77%
Change (1 day)
51.62%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company